Lancome Tropiques Minerale Mineral Smoothing Pressed Bronzer SPF 15 Sunscreen

Dosage form: powder
Ingredients: Octinoxate 0.75g in 10g
Labeler: L'Oreal USA Products Inc
NDC Code: 49967-564

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active ingredient

Octinoxate 7.5%

Directions

Apply before sun exposure.

Warnings

WARNINGS: FOR EXTERNAL USE ONLY. AVOID CONTACT WITH EYES. DISCONTINUE USE IF SIGNS OF IRRITATION OR RASH APPEAR. KEEP OUT OF REACH OF CHILDREN. KEEP PRODUCT AT ROOM TEMPERATURE.

Inactive ingredients

CALCIUM CARBONATE, SILICA, CALCIUM SULFATE, ISOCETYL STEARATE, MAGNESIUM STEARATE, ALOE BARBADENSIS LEAF JUICE, ALUMINA, ETHYLHEXYL-GLYCERIN, TOCOPHEROL ACETATE, CAPRYLYL GLYCOL; MAY CONTAIN: MICA, BETA-CAROTENE, TITANIUM DIOXIDE, BISMUTH OXYCHLORIDE, IRON OXIDES.

LANCOME TROPIQUES MINERALE  MINERAL SMOOTHING PRESSED BRONZER SPF 15 SUNSCREEN
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-564
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.75 g  in 10 g
Packaging
#Item CodePackage Description
1NDC:49967-564-011 CONTAINER (CONTAINER) in 1 CARTON
110 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35204/15/2011
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIOperations
L'Oreal USA Products Inc185931458manufacture

Revised: 04/2011
 
L'Oreal USA Products Inc

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)